How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Implications

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|16|3|266-278

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.16, Iss.3, 2017-04, pp. : 266-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune-Inflammatory Responses and Oxidative Stress in Alzheimers Disease: Therapeutic Implications

By  

Current Pharmaceutical Design, Vol. 16, Iss. 6, 2010-02 ,pp. : 684-691

Bentham Science Publishers

Access to resources Recommend Favorite

Implications of Gliotransmission for the Pharmacotherapy of CNS Disorders

By Rossi Daniela   Martorana Francesca   Brambilla Liliana  

CNS Drugs, Vol. 25, Iss. 8, 2011-08 ,pp. : 641-658

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issue: The Kynurenine and Melatonergic Pathways in Psychiatric and CNS Disorders)

By  

Current Pharmaceutical Design, Vol. 22, Iss. 8, 2016-02 ,pp. : 947-948

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders

By  

Current Drug Targets, Vol. 13, Iss. 6, 2012-05 ,pp. : 842-862

Bentham Science Publishers

Access to resources Recommend Favorite

Multimodal Treatments versus Pharmacotherapy Alone in Children with Psychiatric Disorders: Implications of Access, Effectiveness, and Contextual Treatment

By Reeves Gloria   Anthony Bruno  

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 165-169

Adis International

Access to resources Recommend Favorite